Cite
HARVARD Citation
Mazza, S. et al. (n.d.). Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: safety and survival. Digestive and liver disease. pp. e35-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mazza, S. et al. (n.d.). Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: safety and survival. Digestive and liver disease. pp. e35-. [Online].